US Stock MarketDetailed Quotes

CCCC C4 Therapeutics

Watchlist
  • 3.180
  • -0.020-0.63%
Close Feb 14 16:00 ET
  • 3.190
  • +0.010+0.31%
Post 19:59 ET
224.47MMarket Cap-1.86P/E (TTM)

C4 Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
21.41%-24.13M
73.82%-4.97M
45.30%-18.12M
-0.85%-106.84M
17.57%-24.01M
-9.59%-30.71M
14.41%-19M
-24.55%-33.13M
-21.82%-105.94M
-13.47%-29.13M
Net income from continuing operations
8.77%-24.67M
50.68%-17.72M
18.46%-28.36M
-3.37%-132.49M
6.54%-34.75M
15.40%-27.04M
-31.04%-35.92M
-9.99%-34.78M
-52.79%-128.18M
-137.48%-37.19M
Operating gains losses
----
----
----
--621K
--0
----
----
----
----
----
Depreciation and amortization
-1.12%442K
-2.18%448K
-17.80%448K
12.17%1.88M
-17.47%430K
7.71%447K
5.29%458K
78.69%545K
12.33%1.68M
61.30%521K
Other non cash items
-0.36%1.65M
-2.01%1.71M
-13.74%1.49M
0.48%6.64M
-9.58%1.52M
-1.96%1.65M
-7.38%1.75M
26.84%1.73M
209.70%6.61M
173.78%1.68M
Change In working capital
33.31%-9M
-37.41%5.87M
153.97%3.36M
58.65%-6.94M
615.61%3.4M
-220.72%-13.5M
265.40%9.38M
0.37%-6.22M
44.24%-16.78M
96.36%-660K
-Change in receivables
-1,837.50%-9.17M
2,586.20%12.43M
-290.37%-1.8M
-343.33%-10.33M
-75,433.33%-11.3M
137.84%528K
-893.65%-500K
-76.04%945K
444.48%4.24M
101.72%15K
-Change in prepaid assets
217.92%816K
-127.91%-446K
-1,037.75%-4.67M
601.80%2.72M
671.35%1.32M
54.02%-692K
13.09%1.6M
61.17%498K
106.34%388K
103.42%171K
-Change in payables and accrued expense
403.31%4.76M
-252.60%-2.47M
-96.45%-7.48M
-9.20%1.59M
231.13%5.35M
-300.00%-1.57M
-62.13%1.62M
22.57%-3.81M
-45.28%1.75M
-44.18%1.62M
-Change in other current liabilities
-11.01%-1.32M
-10.98%-1.3M
-11.74%-1.26M
-826.04%-4.7M
-11.46%-1.21M
-176.38%-1.19M
8.70%-1.18M
-469.74%-1.12M
42.91%-507K
-832.76%-1.08M
-Change in other working capital
61.38%-4.08M
-129.95%-2.35M
779.71%18.56M
116.65%3.77M
769.49%9.24M
-100.68%-10.57M
177.40%7.84M
53.57%-2.73M
9.57%-22.65M
90.84%-1.38M
Cash from discontinued investing activities
Operating cash flow
21.41%-24.13M
73.82%-4.97M
45.30%-18.12M
-0.85%-106.84M
17.57%-24.01M
-9.59%-30.71M
14.41%-19M
-24.55%-33.13M
-21.82%-105.94M
-13.47%-29.13M
Investing cash flow
Cash flow from continuing investing activities
-99.72%162K
-177.28%-11.71M
-199.75%-53.4M
171.04%158.35M
244.09%31.95M
189.87%57.73M
-54.41%15.15M
1,436.94%53.53M
130.86%58.42M
115.63%9.28M
Net PPE purchase and sale
102.17%13K
45.58%-197K
--0
68.92%-1.71M
89.46%-157K
81.85%-600K
31.57%-362K
-242.44%-589K
-330.38%-5.5M
-1,266.97%-1.49M
Net investment purchase and sale
-99.74%149K
-174.20%-11.51M
-198.66%-53.4M
150.41%160.06M
197.96%32.1M
151.20%58.33M
-54.05%15.51M
1,512.32%54.12M
133.99%63.92M
118.17%10.77M
Cash from discontinued investing activities
Investing cash flow
-99.72%162K
-177.28%-11.71M
-199.75%-53.4M
171.04%158.35M
244.09%31.95M
189.87%57.73M
-54.41%15.15M
1,436.94%53.53M
130.86%58.42M
115.63%9.28M
Financing cash flow
Cash flow from continuing financing activities
197.70%10.51M
118.10%135K
5,155.99%34.58M
3,865.91%45.49M
122,606.38%57.67M
-3,078.67%-10.75M
-388.03%-746K
-242.50%-684K
-99.33%1.15M
-89.91%47K
Net issuance payments of debt
--0
--0
--0
---12.5M
--0
---11M
---750K
---750K
--0
--0
Net common stock issuance
63,825.00%10.2M
--0
36,248.94%33.98M
--57.56M
--57.67M
---16K
--0
---94K
--0
--0
Proceeds from stock option exercised by employees
--13K
6,650.00%135K
826.79%519K
-92.54%58K
--0
--0
-99.23%2K
-78.46%56K
-66.65%777K
-93.75%47K
Net other financing activities
12.93%297K
--0
-19.23%84K
-0.54%368K
---1K
75.33%263K
--2K
-52.73%104K
193.67%370K
--0
Cash from discontinued financing activities
Financing cash flow
197.70%10.51M
118.10%135K
5,155.99%34.58M
3,865.91%45.49M
122,606.38%57.67M
-3,078.67%-10.75M
-388.03%-746K
-242.50%-684K
-99.33%1.15M
-89.91%47K
Net cash flow
Beginning cash position
58.96%76.56M
76.48%93.1M
293.65%130.03M
-58.40%33.03M
21.95%64.43M
-20.50%48.16M
7.05%52.76M
-58.40%33.03M
-56.92%79.4M
-67.79%52.83M
Current changes in cash
-182.79%-13.47M
-260.07%-16.55M
-287.26%-36.93M
309.19%97M
431.40%65.61M
310.01%16.27M
-140.69%-4.6M
165.48%19.72M
55.80%-46.37M
76.60%-19.8M
End cash Position
-2.07%63.09M
58.96%76.56M
76.48%93.1M
293.65%130.03M
293.65%130.03M
21.95%64.43M
-20.50%48.16M
7.05%52.76M
-58.40%33.03M
-58.40%33.03M
Free cash flow
22.96%-24.12M
73.29%-5.17M
46.26%-18.12M
2.59%-108.55M
21.07%-24.17M
0.06%-31.31M
14.81%-19.36M
-25.95%-33.71M
-26.28%-111.44M
-18.77%-30.62M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 21.41%-24.13M73.82%-4.97M45.30%-18.12M-0.85%-106.84M17.57%-24.01M-9.59%-30.71M14.41%-19M-24.55%-33.13M-21.82%-105.94M-13.47%-29.13M
Net income from continuing operations 8.77%-24.67M50.68%-17.72M18.46%-28.36M-3.37%-132.49M6.54%-34.75M15.40%-27.04M-31.04%-35.92M-9.99%-34.78M-52.79%-128.18M-137.48%-37.19M
Operating gains losses --------------621K--0--------------------
Depreciation and amortization -1.12%442K-2.18%448K-17.80%448K12.17%1.88M-17.47%430K7.71%447K5.29%458K78.69%545K12.33%1.68M61.30%521K
Other non cash items -0.36%1.65M-2.01%1.71M-13.74%1.49M0.48%6.64M-9.58%1.52M-1.96%1.65M-7.38%1.75M26.84%1.73M209.70%6.61M173.78%1.68M
Change In working capital 33.31%-9M-37.41%5.87M153.97%3.36M58.65%-6.94M615.61%3.4M-220.72%-13.5M265.40%9.38M0.37%-6.22M44.24%-16.78M96.36%-660K
-Change in receivables -1,837.50%-9.17M2,586.20%12.43M-290.37%-1.8M-343.33%-10.33M-75,433.33%-11.3M137.84%528K-893.65%-500K-76.04%945K444.48%4.24M101.72%15K
-Change in prepaid assets 217.92%816K-127.91%-446K-1,037.75%-4.67M601.80%2.72M671.35%1.32M54.02%-692K13.09%1.6M61.17%498K106.34%388K103.42%171K
-Change in payables and accrued expense 403.31%4.76M-252.60%-2.47M-96.45%-7.48M-9.20%1.59M231.13%5.35M-300.00%-1.57M-62.13%1.62M22.57%-3.81M-45.28%1.75M-44.18%1.62M
-Change in other current liabilities -11.01%-1.32M-10.98%-1.3M-11.74%-1.26M-826.04%-4.7M-11.46%-1.21M-176.38%-1.19M8.70%-1.18M-469.74%-1.12M42.91%-507K-832.76%-1.08M
-Change in other working capital 61.38%-4.08M-129.95%-2.35M779.71%18.56M116.65%3.77M769.49%9.24M-100.68%-10.57M177.40%7.84M53.57%-2.73M9.57%-22.65M90.84%-1.38M
Cash from discontinued investing activities
Operating cash flow 21.41%-24.13M73.82%-4.97M45.30%-18.12M-0.85%-106.84M17.57%-24.01M-9.59%-30.71M14.41%-19M-24.55%-33.13M-21.82%-105.94M-13.47%-29.13M
Investing cash flow
Cash flow from continuing investing activities -99.72%162K-177.28%-11.71M-199.75%-53.4M171.04%158.35M244.09%31.95M189.87%57.73M-54.41%15.15M1,436.94%53.53M130.86%58.42M115.63%9.28M
Net PPE purchase and sale 102.17%13K45.58%-197K--068.92%-1.71M89.46%-157K81.85%-600K31.57%-362K-242.44%-589K-330.38%-5.5M-1,266.97%-1.49M
Net investment purchase and sale -99.74%149K-174.20%-11.51M-198.66%-53.4M150.41%160.06M197.96%32.1M151.20%58.33M-54.05%15.51M1,512.32%54.12M133.99%63.92M118.17%10.77M
Cash from discontinued investing activities
Investing cash flow -99.72%162K-177.28%-11.71M-199.75%-53.4M171.04%158.35M244.09%31.95M189.87%57.73M-54.41%15.15M1,436.94%53.53M130.86%58.42M115.63%9.28M
Financing cash flow
Cash flow from continuing financing activities 197.70%10.51M118.10%135K5,155.99%34.58M3,865.91%45.49M122,606.38%57.67M-3,078.67%-10.75M-388.03%-746K-242.50%-684K-99.33%1.15M-89.91%47K
Net issuance payments of debt --0--0--0---12.5M--0---11M---750K---750K--0--0
Net common stock issuance 63,825.00%10.2M--036,248.94%33.98M--57.56M--57.67M---16K--0---94K--0--0
Proceeds from stock option exercised by employees --13K6,650.00%135K826.79%519K-92.54%58K--0--0-99.23%2K-78.46%56K-66.65%777K-93.75%47K
Net other financing activities 12.93%297K--0-19.23%84K-0.54%368K---1K75.33%263K--2K-52.73%104K193.67%370K--0
Cash from discontinued financing activities
Financing cash flow 197.70%10.51M118.10%135K5,155.99%34.58M3,865.91%45.49M122,606.38%57.67M-3,078.67%-10.75M-388.03%-746K-242.50%-684K-99.33%1.15M-89.91%47K
Net cash flow
Beginning cash position 58.96%76.56M76.48%93.1M293.65%130.03M-58.40%33.03M21.95%64.43M-20.50%48.16M7.05%52.76M-58.40%33.03M-56.92%79.4M-67.79%52.83M
Current changes in cash -182.79%-13.47M-260.07%-16.55M-287.26%-36.93M309.19%97M431.40%65.61M310.01%16.27M-140.69%-4.6M165.48%19.72M55.80%-46.37M76.60%-19.8M
End cash Position -2.07%63.09M58.96%76.56M76.48%93.1M293.65%130.03M293.65%130.03M21.95%64.43M-20.50%48.16M7.05%52.76M-58.40%33.03M-58.40%33.03M
Free cash flow 22.96%-24.12M73.29%-5.17M46.26%-18.12M2.59%-108.55M21.07%-24.17M0.06%-31.31M14.81%-19.36M-25.95%-33.71M-26.28%-111.44M-18.77%-30.62M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--

Trending Stocks

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

No. Symbol Price
Citigroup
C
84.610
Bank of America
BAC
46.960
Apple
AAPL
244.600
4
American Express
AXP
311.040
5
Chevron
CVX
155.340
Log In for the Full List
Unlock Now
Headlines
The Fed's "hawkish tone" continues! Board member Waller: supports holding steady for now, with interest rate adjustments depending only on data.
just
Earnings Report Preview | UBS Group expects Alibaba's Q3 revenue to grow by 5.5% year-on-year. Proper execution of the Global Strategy will unlock long-term value.
53 mins ago
Is Musk targeting the SEC? The DOGE has sparked a "storm of audits", and a "360-year-old" recipient has appeared in the US social security system.
11:11
Do the top ten tech companies in China have an ROI that exceeds the "seven giants" of the US stock market? The valuation level remains attractive even after a surge.
Feb 17 20:41
Market Overview | Hong Kong stocks continue to rise, the Tech Index increased by nearly 2% again! Network Technology stocks, Autos and others are strongly attacking, Xiaomi Group rose by 6%, Alibaba rose by more than 4%.
10:36